OCGN

Ocugen News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Ocugen Inc OCGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.05 1.81% 2.82 00:00:10
Open Price Low Price High Price Close Price Prev Close
2.73 2.68 2.95 2.86 2.77
more quote information »

Recent News

Date Time Source Heading
8/05/202209:24EDGARQuarterly Report (10-q)
8/05/202207:36EDGARCurrent Report Filing (8-k)
8/05/202207:30GLOBEOcugen Provides Business Update & Second Quarter 2022..
7/29/202207:30GLOBEOcugen To Host Conference Call on Friday, August 5 at 8:30..
7/20/202216:19EDGARStatement of Changes in Beneficial Ownership (4)
6/21/202207:00GLOBEOcugen Announces Publication of Positive Results of..
6/14/202207:00GLOBEOcugen Named Among Philadelphia’s ‘2022 Best Places to Work’
6/13/202207:00GLOBEOcugen, Inc. Announces Issuance of U.S. Patent for Treating..
6/09/202218:17GLOBEOcugen, Inc. to Present at BIO International Convention 2022
6/07/202216:12EDGARCurrent Report Filing (8-k)
5/26/202206:13EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/24/202207:11GLOBEOcugen Announces New Cell Therapy Program Following FDA..
5/24/202206:27TRMNH.C. Wainwright Thinks Ocugen’s Stock is Going to Recover
5/23/202209:03EDGARCurrent Report Filing (8-k)
5/23/202207:34GLOBEOcugen, Inc. to Present at H.C. Wainwright Global Investment..
5/23/202206:36GLOBEOcugen Announces FDA Removes Clinical Hold on Phase 2/3..
5/20/202216:06EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/18/202216:07EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/13/202216:13EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/13/202216:05EDGARStatement of Changes in Beneficial Ownership (4)
5/12/202206:27TRMNH.C. Wainwright Thinks Ocugen’s Stock is Going to Recover
5/09/202208:05TRMNNoble Financial Keeps a Buy Rating on Ocugen (OCGN)
5/06/202206:33GLOBEOcugen Provides Business Update and First Quarter 2022..
5/02/202207:37GLOBEOcugen to Host Conference Call on Friday, May 6 at 8:30 a.m...
4/29/202211:36GLOBEOcugen, Inc. to Present Preclinical Results at The..
4/28/202216:14EDGARProxy Statement (definitive) (def 14a)
4/25/202207:33GLOBEOcugen, Inc. Announces Positive DSMB Recommendation for..
4/20/202216:03EDGARStatement of Changes in Beneficial Ownership (4)
4/19/202217:32GLOBEOcugen, Inc. to Present at NobleCon18
4/18/202208:08EDGARCurrent Report Filing (8-k)
4/18/202207:11GLOBEOcugen, Inc. to Commercialize COVAXIN™ in Mexico, Rights Now..
4/12/202209:08EDGARCurrent Report Filing (8-k)
4/12/202208:31GLOBEOcugen, Inc. Provides Update on its Phase 2/3 Study of..
4/11/202214:14EDGARAmended Statement of Ownership (sc 13g/a)
4/04/202208:26TRMNNoble Financial Thinks Ocugen’s Stock is Going to Recover
4/02/202223:31SEEKOcugen partnered COVID-19 shot suspended by WHO for UN..
4/01/202208:04SEEKOcugen initiates dosing in Phase 1/2 trial for retinitis..
4/01/202207:37GLOBEOcugen, Inc. Announces First Patient Dosed in Phase 1/2..
3/23/202219:25EDGARStatement of Changes in Beneficial Ownership (4)
3/23/202207:44GLOBEOcugen Announces Appointment of Marna C. Whittington, PhD,..
3/23/202207:31EDGARCurrent Report Filing (8-k)
3/22/202218:46EDGARStatement of Changes in Beneficial Ownership (4)
3/22/202218:44EDGARInitial Statement of Beneficial Ownership (3)
3/21/202218:36GLOBEOcugen, Inc. Appoints Jessica Crespo, CPA, to Chief..
3/18/202217:56GLOBEOcugen Inc. Announces Inducement Grants Under Nasdaq Listing..
3/18/202216:04EDGARStatement of Changes in Beneficial Ownership (4)
3/11/202216:25EDGARCurrent Report Filing (8-k)
3/09/202207:11GLOBEOcugen, Inc. to Present at the 34th Annual ROTH Conference
3/07/202208:35TRMNNoble Financial Thinks Ocugen’s Stock is Going to Recover
3/07/202205:09TRMNOcugen’s COVAXIN Denied by FDA for Pediatric Emergency Use;..


Your Recent History
NASDAQ
OCGN
Ocugen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now